Diagnostic and prognostic significance of receptor‐binding cancer antigen expressed on SiSo cells in lung‐cancer‐associated pleural effusion

Abstract

In conclusion, measurement of sRCAS1 might be a useful diagnostic and prognostic marker for MPE.

Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion

“…Research show that the incidence of malignant effusion in patients with lung cancer is about 7–23%23 and occurs in 15% of cancer-related deaths1, which usually leads to debilitating dyspnoea, worsening quality of life and a poor survival. However, its treatment is quite difficult2. The present treatments of MPE included the drainage of pleural effusion, intrapleural chemotherapy and systemic chemotherapy.…”

“…The present treatments of MPE included the drainage of pleural effusion, intrapleural chemotherapy and systemic chemotherapy. Unfortunately, not all patients with MPE can benefit from quasi chemotherapy and treatment123.…”